These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7408408)

  • 1. Effect of dose on phenytoin absorption.
    Jung D; Powell JR; Walson P; Perrier D
    Clin Pharmacol Ther; 1980 Oct; 28(4):479-85. PubMed ID: 7408408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption characteristics of three phenytoin sodium products after administration of oral loading doses.
    Goff DA; Spunt AL; Jung D; Bellur SN; Fischer JH
    Clin Pharm; 1984; 3(6):634-8. PubMed ID: 6509876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin: pharmacokinetics and bioavailability.
    Gugler R; Manion CV; Azarnoff DL
    Clin Pharmacol Ther; 1976 Feb; 19(2):135-42. PubMed ID: 1261151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.
    Sawchuk RJ; Rector TS
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):543-55. PubMed ID: 529023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.
    Neuvonen PJ
    Clin Pharmacokinet; 1979; 4(2):91-103. PubMed ID: 378503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral phenytoin in infancy: dose requirement, absorption, and elimination.
    Albani M; Wernicke I
    Pediatr Pharmacol (New York); 1983; 3(3-4):229-36. PubMed ID: 6677874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies in man of phenytoin absorption and its implications.
    Gibberd FB; Webley M
    J Neurol Neurosurg Psychiatry; 1975 Mar; 38(3):219-24. PubMed ID: 1151402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single oral loading dose of phenytoin: a pharmacokinetics study.
    Ratanakorn D; Kaojarern S; Phuapradit P; Mokkhavesa C
    J Neurol Sci; 1997 Mar; 147(1):89-92. PubMed ID: 9094065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the bioavailability of five different phenytoin preparations.
    Hirji MR; Measuria H; Kuhn S; Mucklow JC
    J Pharm Pharmacol; 1985 Aug; 37(8):570-2. PubMed ID: 2864420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
    Frey HH; Löscher W
    Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of two different phenytoin preparations. Evidence for an age dependency.
    Matsukura M; Ikeda T; Higashi A; Matsuda I
    Dev Pharmacol Ther; 1984; 7(3):160-8. PubMed ID: 6723491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High intravenous phenytoin dosage requirement in a newborn infant.
    Whelan HT; Hendeles L; Haberkern CM; Neims AH
    Neurology; 1983 Jan; 33(1):106-8. PubMed ID: 6681550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a simplified method to determine bioavailability of an oral dose of phenytoin.
    Davis AL; Begg EJ; Kennedy MC; Graham GG
    J Pharmacokinet Biopharm; 1993 Apr; 21(2):195-208. PubMed ID: 8229680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin absorption in patients with ileojejunal bypass.
    Kennedy MC; Wade DN
    Br J Clin Pharmacol; 1979 May; 7(5):515-8. PubMed ID: 475946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
    Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
    J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin disposition in obesity. Determination of loading dose.
    Abernethy DR; Greenblatt DJ
    Arch Neurol; 1985 May; 42(5):468-71. PubMed ID: 3994563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin metabolism in infants following intravenous and oral administration.
    Leff RD; Fischer LJ; Roberts RJ
    Dev Pharmacol Ther; 1986; 9(4):217-23. PubMed ID: 3757729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-aided dosage form design. III. Feasibility assessment for an oral prolonged-release phenytoin product.
    Irvin JR; Notari RE
    Pharm Res; 1991 Feb; 8(2):232-7. PubMed ID: 2023873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.